Thalidomide

Dangerous originally, repurposed safely
One reason for the low success rate of novel drug development is the high percentage of adverse side effects found in late-stage clinical trials. However, failed drugs can be repurposed for different diseases with new patient populations that would not be affected by such side effects, creating benefit for both pharmaceutical companies and for patients.